Neuralstem

CUR NASDAQ
0.4647
+0.0047
+1.02%
Opening 10:56 05/23 EDT
Open
0.4706
Prev Close
0.4600
High
0.4756
Low
0.4450
Volume
10.40K
Avg Vol (3M)
230.76K
52 Week High
1.780
52 Week Low
0.2502
% Turnover
0.05%
Market Cap
9.30M
1D
5D
1M
3M
1Y
5Y

Comments

No Data

Company Profile

Neuralstem, Inc. (Neuralstem) is a clinical-stage biopharmaceutical company. The Company is engaged in research, development and commercialization of central nervous system therapies based on its human neuronal stem cells and its stem-cell derived small molecule compounds. The Company has approximately three assets: its NSI-189 small molecule program, its NSI-566 stem cell therapy program and its chemical entity screening platform. The Company's technology allows the commercial-scale production of multiple types of central nervous system stem cells, which are under development for the treatment of central nervous system diseases and conditions. The Company is developing NSI-189 for the treatment of major depressive disorder (MDD) and other psychiatric and/or cognitive impairment indications associated with hippocampal atrophy. The Company's NSI-566 is indicated for amyotrophic lateral sclerosis (ALS), chronic spinal cord injury and motor deficits due to ischemic stroke.
MORE >

Recently

Name
Price
%Change